Genomic meta-analysis of growth factor and integrin pathways in chronic kidney transplant injury

Amrita Dosanjh1, Elizabeth Robison, Tony Mondala

  • 1Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA.

BMC Genomics
|April 27, 2013
PubMed
Abstract

Insights

Chronic Allograft Nephropathy (CAN) involves kidney transplant injury. Key growth factors and integrins correlate with disease progression, offering new therapeutic targets for kidney fibrosis.

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Bioinformatics

Background:

  • Chronic Allograft Nephropathy (CAN) is a major cause of kidney transplant failure, histologically defined by interstitial fibrosis and tubular atrophy (IFTA).
  • Understanding the molecular pathways driving CAN progression is crucial for developing effective treatments.
  • Previous studies suggested a role for growth factors and adhesion molecules in transplant injury.

Purpose of the Study:

  • To identify differentially expressed pathways and molecules associated with the progression of Chronic Allograft Nephropathy (CAN) and interstitial fibrosis and tubular atrophy (IFTA).
  • To leverage bioinformatics and meta-analysis to uncover novel correlative changes in integrin and growth factor signaling pathways in kidney transplant biopsies.
  • To explore potential therapeutic targets for preventing or treating progressive kidney transplant dysfunction.

Main Methods:

  • Conducted a meta-analysis of microarrays from 84 kidney transplant biopsies with varying grades of CAN/IFTA.
  • Employed bioinformatics approaches to mine independent datasets for correlative changes in signaling pathways.
  • Validated findings using proteomic profiling of CAN/IFTA.

Main Results:

  • Hepatocyte growth factor (HGF) and epidermal growth factor (EGF) pathways, along with MAPK-dependent pathways, were significantly differentially expressed in all CAN/IFTA grades.
  • Specific integrin subunits (β8, αv, αμ, β5) were differentially expressed, while others (β1, β6, α6) correlated with the progression of chronic kidney injury.
  • TGFβ pathways were present but did not differentiate CAN/IFTA progression.

Conclusions:

  • CAN/IFTA is characterized by the distinct expression of specific growth factors and integrin adhesion molecules and their signaling pathways.
  • The study identified novel molecular targets for next-generation therapeutics aimed at preventing or treating progressive kidney transplant dysfunction.
  • Target mapping suggests potential drug candidates for managing interstitial fibrosis in kidney allografts.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...